S&P 500 cuts losses as Nvidia climbs ahead of results
Investing.com - LENSAR reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
LENSAR announced earnings per share of $-0.390 on revenue of $7.7M. Analysts polled by Investing.com EPS of $-0.670 on revenue of $9.8M.
LENSAR 's are down 16.73% and is trading at $4.500 , still down 48.42% from its 52 week high of $8.80 set on Monday, March 28, 2022.
LENSAR shares lost 0.86% to trade at $4.500 in pre-market trade the report.
LENSAR follows other major Healthcare sector earnings this month
LENSAR's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar